Cowin Capital is a private equity general partner firm headquartered in Shenzhen, China and has other offices in China.
Clinical-stage company Connect Biopharmaceuticals has completed a $20m Series A round from Qiming Venture Partners and others.
Shenzhen Cowin Capital will exit jewelry retailer Myray to Gansu Gangtai Holdings, which will buy a further 36.96% of Myray for RMB170m.
Shenzhen Cowin Capital has led a RMB100m Series B round for Hao Chushi, a Chinese mobile app for booking private chef services.
Read more news concerning Cowin Capital
A sampling of Cowin Capital portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?